Skip to main content
SpringerLink
Log in

Human Colon Carcinomas Constitutively Express and Shed Type II IL-1 Receptor, an IL-1 Antagonist

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

We reported earlier that rat intestinal epithelial cells respond to helminth infection, to NSAID injury, and to detachment in vitro with expression of the IL-1RII. Now we have sought to determine whether human colon carcinoma cell lines express, or may be induced to express, this potent IL-1 antagonist. Using RT-PCR, the T84 and HT-29 cell lines constitutively expressed mRNA for the membrane-bound, but not the secreted variant of the receptor. The protein was detectable by immunohistochemistry and was estimated to be 70 kDa by western blotting. TNF treatment of T84 cells led to slightly increased levels of IL-1RII mRNA and to significant increases in soluble protein detected in culture supernatants. Treating T84 cells with inhibitory anti-IL-1RII antibodies led to heightened responsiveness to IL-1, measured as IL-8 production. Expression of the IL-1RII by human epithelial cells has implications in terms of the IL-1 agonist versus antagonist balance in the diseased intestines.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Dinarello CA: Biologic basis for interleukin-1 in disease. Blood 87:2095–2147, 1996

    Google Scholar 

  2. Mazlam MZ, Hodgson HJF: Interrelations between interleukin-6, interleukin-1β, plasma C-reactive protein values, and in vitro C-reactive protein generation in patients with inflammatory bowel disease. Gut 35:77–83, 1994

    Google Scholar 

  3. Cappello M, Keshav S, Prince C, Jewell DP, Gordon S: Detection of mRNAs for macrophage products in inflammatory bowel disease by in situ hybridisation. Gut 33:1214–1219, 1992

    Google Scholar 

  4. Olson AD, Ayass M, Chensue S: Tumor necrosis factor and IL-1β expression in pediatric patients with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 16:241–246, 1993

    Google Scholar 

  5. Nakamura M, Saito H, Kasanuki J, Tamura Y, Yoshida S: Cytokine production in patients with inflammatory bowel disease. Gut 33:933–937, 1992

    Google Scholar 

  6. Mazlam MZ, Hodgson HJF: Peripheral blood monocyte cytokine production and acute phase response in inflammatory bowel disease. Gut 33:773–778, 1992

    Google Scholar 

  7. Brynskov J, Tvede N, Anderson CB, Vilien M: Increased concentrations of interleukin 1β, interleukin-2, and soluble interleukin-2 receptors in endoscopial mucosal biopsy specimens with active inflammatory bowel disease. Gut 33:55–58, 1992

    Google Scholar 

  8. Thomas TK, Will PC, Srivastava A, Wilson CL, Harbison M, Little J, Chesonis RS, Pignatello M, Schmolze D, Symington J, Kilian PL, Thompson RC: Evaluation of an interleukin-1 receptor antagonist in the rat acetic acid-induced colitis model. Agents Actions 34:187–190, 1991

    Google Scholar 

  9. Cominelli F, Nast CC, Clark BD, Schindler R, Llerena R, Eysselein VE: Interleukin 1 (IL-1) gene expression, synthesis, and effect of specific IL-1 receptor blockade in rabbit immune complex colitis. J Clin Invest 86:972–980, 1990

    Google Scholar 

  10. Cominelli F, Nast CC, Duchini A, Lee M: Recombinant interleukin-1 receptor antagonist blocks the proinflammatory activity of endogenous interleukin-1 in rabbit immune colitis. Gastroenterology 103:65–71, 1992

    Google Scholar 

  11. Casini-Raggi V, Kam L, Chong YJT, Fiocchi C, Pizarro TT, Cominelli F: Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease: a novel mechanism of chronic intestinal inflammation. J Immunol 154:2434–2440, 1995

    Google Scholar 

  12. Troncone R, Caputo N, Campanozzi A, Cucciardi M, Esposito V, Russo R, De Vizia B, Greco L, Cucchiara S: Gut lavage IgG and interleukin 1 receptor antagonist: interleukin 1β ratio as markers of intestinal inflammation in children with inflammatory bowel disease. Gut 41:60–65, 1997

    Google Scholar 

  13. Andus T, Daig R, Vogl D, Aschenbrenner E, Lock G, Hollerbach S, Köllinger M, Schölmerich J, Gross V: Imbalance of the interleukin 1 system in colonic mucosa—association with intestinal inflammation and interleukin 1 receptor agonist genotype 2. Gut 41:651–657, 1997

    Google Scholar 

  14. Dionne S, D'Agata ID, Hiscott J, Vanounou T, Seidman EG: Colonic explant production of IL-1 and its receptor antagonist is imbalanced in inflammatory bowel disease (IBD). Clin Exper Immunol 112:435–442, 1998

    Google Scholar 

  15. Hacker UT, Bidlingmaier C, Gomolka M, Keller E, Eigler A, Hartmann G, Folwaczny C, Fricke H, Albert E, Loeschke K, Endres S: Inflammatory bowel disease: no association between allele combinations of the interleukin (IL) 1β and IL-1 receptor antagonist gene polymorphisms. Eur J Clin Invest 28:214–219, 1998

    Google Scholar 

  16. Stokkers PCF, Van Aken BE, Basoski N, Reitsma PH, Tytgat GNJ, Van Deventer SJH: Five genetic markers in the interleukin 1 family in relation to inflammatory bowel disease. Gut 43:33–39, 1998

    Google Scholar 

  17. Nemetz A, Nosti-Escanilla MP, Molnár T, Köpe A, Kovács A, Fehér J, Tulassay Z, Nagy F, García-González MA, Peña AS: IL1B gene polymorphisms influence the course and severity of inflammatory bowel disease. Immunogenetics 49:527–531, 1999

    Google Scholar 

  18. Nemetz A, Köpe A, Molnár T, Kovács A, Fehér J, Tulassay Z, Nagy F, García-González MA, Peña AS: Significant differences in the interleukin-1β and interleukin-1 receptor antagonist gene polymorphisms in a Hungarian population with inflammatory bowel disease. Scand J Gastroenterol 34:175–179, 1999

    Google Scholar 

  19. Sims JE, Giri JG, Dower SK: The two interleukin-1 receptors play different roles in IL-1 actions. Clin Immunol Immunopathol 72:9–14, 1994

    Google Scholar 

  20. Colotta F, Re F, Muzio M, Bertini R, Polentarutti N, Sironi M, Giri JG, Dower SK, Sims JE, Mantovani A: Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science 261:472–475, 1993

    Google Scholar 

  21. Neumann D, Kollewe C, Martin MU, Boraschi D: The membrane form of the type II IL-1 receptor accounts for inhibitory function. J Immunol 165:3350–3357, 2000

    Google Scholar 

  22. Giri JG, Newton RC, Horuk R: Identification of soluble interleukin-1 binding protein in cell-free supernatants. J Biol Chem 265:17416–17419, 1990

    Google Scholar 

  23. Colotta F, Saccani S, Giri JG, Dower SK, Sims JE, Introna M, Mantovani A: Regulated expression and release of the IL-1 decoy recptor in human mononuclear phagocytes. J Immunol 156:2534–2541, 1996

    Google Scholar 

  24. Orlando S, Matteucci C, Fadlon EJ, Buurman WA, Bardella MT, Colotta F, Introna M, Mantovani A: TNF-α, unlike other pro-and anti-inflammatory cytokines, induces rapid release of the IL-1 type II decoy receptor in human myelomonocytic cells. J Immunol 158:3861–3868, 1997

    Google Scholar 

  25. Arend WP, Malyak M, Smith MF Jr, Whisenand TD, Slack JL, Sims JE, Giri JG, Dower SK: Binding of IL-1α, IL-1β receptor antagonist by soluble IL-1 receptors and levels of soluble IL-1 receptors in synovial fluids. J Immunol 153:4766–4774, 1994

    Google Scholar 

  26. Van Deuren M, Van der Ven-Jongekrijg J, Vannier E, Van Dalen R, Pesman G, Bartelink AKM, Dinarello CA, Van der Meer JWM: The pattern of interleukin-1β (IL-1β) and its modulating agents IL-1 receptor antagonist and IL-1 soluble receptor type II in acute meningococcal infections. Blood 90:1101–1108, 1997

    Google Scholar 

  27. Vannier E, Kaser A, Atkins MB, Fantuzzi G, Dinarello CA, Mier JW, Tilg H: Elevated circulating levels of soluble interleukin-1 receptor type II during interleukin-2 immunotherapy. Eur Cytok Net 10:37–41, 1999

    Google Scholar 

  28. Mantovani A, Locati M, Vecchi A, Sozzani S, Allavena P: Decoy receptors: a strategy to regulate inflammatory cytokines and chemokines. Trend Immunol 22:328–336, 2001

    Google Scholar 

  29. Liu CL, Hart RP, Liu XJ, Clevenger W, Maki RA, De Souza EB: Cloning and characterization of an alternatively processed human type II interleukin-1 receptor mRNA. J Biol Chem 271:20965–20972, 1996

    Google Scholar 

  30. Cubitt CL, Lausch RN, Oakes JE: Synthesis of Type II interleukin-1 receptors by human corneal epithelial cells but not by keratocytes. Invest Ophthalmol Vis Sci 42:701–704, 2001

    Google Scholar 

  31. Groves RW, Giri J, Sims J, Dower SK, Kupper TS: Inducible expression of Type 2 IL-1 receptors by cultured human keratinocytes. Implications for IL-1 mediated processes in epidermis. J Immunol 154:4065–4072, 1995

    Google Scholar 

  32. Waterhouse CCM, Stadnyk AW: Rapid expression of IL-1β by intestinal epithelial cells in vitro. Cell Immunol 193:1–8, 1999

    Google Scholar 

  33. Stadnyk AW, Dollard CD, Issekutz AC: Neutrophil migration stimulates epithelial cell cytokines during T. spiralis infection of the rat. J Leukoc Biol 68:821–827, 2000

    Google Scholar 

  34. Stadnyk AW, Dollard CD, Issekutz TB, Issekutz AC: Neutrophil migration into indomethacin-induced rat small intestinal injury is CD11a/CD18 and CD11b/CD18 co-dependent. Gut 50:629–635, 2002

    Google Scholar 

  35. Lowe T, Sharefkin J, Yang SQ, Dieffambach CW: A computer program for selection of oligonucleotide primers for polymerase chain reactions. Nuc Acids Res 18:1757–1761, 1990

    Google Scholar 

  36. McGee DW, Vitkus SJD, Lee PY: The effect of cytokine stimulation on IL-1 receptor mRNA expression by intestinal epithelial cells. Cell Immunol 168:276–280, 1996

    Google Scholar 

  37. Stadnyk AW: Intestinal epithelial cells as a source of inflammatory cytokines and chemokines. Can J Gastroenterol 16:241–246, 2002

    Google Scholar 

  38. Eckmann L, Jung HC, Schüerer-Maly C, Panja A, Morzycka-Wroblewska E, Kagnoff MF: Differential cytokine expression by human intestinal epithelial cell lines: Regulated expression of interleukin 8. Gastroenterology 105:1689–1697, 1993

    Google Scholar 

  39. Jobin C, Haskill S, Mayer L, Panja A, Sartor RB: Evidence for altered regulation of IkappaBα degradation in human colonic epithelial cells. J Immunol 158:226–234, 1997

    Google Scholar 

  40. Matsumoto T, Kitano A, Nakamura S, Oshitani N, Obata A, Hiki M, Hashimura H, Okawa K, Kobayashi K, Nagura H: Possible role of vascular endothelial cells in immune responses in colonic mucosa examined immunocytochemically in subjects with and without ulcerative colitis. Clin Exp Immunol 78:424–430, 1989

    Google Scholar 

  41. Radema SA, Tytgat GNJ, Van Deventer SJH: In situ detection of interleukin-1β and interleukin 8 in biopsy specimens from patients with ulcerative colitis. Adv Exp Med Biol 371B PT 2:1297–1299, 1995

    Google Scholar 

  42. Woywodt A, Neustock P, Kruse A, Schwarting K, Ludwig D, Stange EF, Kirchner H: Cytokine expression in intestinal mucosal biopsies. In situ hybridisation of the mRNA for interleukin-1β, interleukin-6 and tumour necrosis factor-α in inflammatory bowel disease. Eur Cytok Net 5:387–395, 1994

    Google Scholar 

  43. Jarry A, Vallette G, Cassagnau E, Moreau A, Bou-Hanna C, Lemarre P, Letessier E, Le Neel JC, Galmiche JP, Laboisse CL: Interleukin 1 and interleukin 1β converting enzyme (caspase 1) expression in the human colonic epithelial barrier. Caspase 1 downregulation in colon cancer. Gut 45:246–251, 1999

    Google Scholar 

  44. Waterhouse CCM, Joseph RR, Stadnyk AW: Endogenous IL-1 and type II IL-1 receptor expression modulate anoikis in intestinal epithelial cells. Exp Cell Res 269:109–116, 2001

    Google Scholar 

  45. Mantovani A, Muzio M, Ghezzi P, Colotta C, Introna M: Regulation of inhibitory pathways of the interleukin-1 system. Ann NY Acad Sci 840:338–351, 1998

    Google Scholar 

  46. Symons JA, Young PR, Duff GW: Soluble type II interleukin 1 (IL-1) receptor binds and blocks processing of IL-1β precursor and loses affinity for IL-1 receptor antagonist. Proc Natl Acad Sci USA 92:1714–1718, 1995

    Google Scholar 

  47. Re F, Muzio M, De Rossi M, Polentarutti N, Giri JG, Mantovani A, Colotta F: The type II receptor as a decoy target for interleukin-1 in polymorphonuclear leukocytes: characterization of induction by dexamethasone and ligand binding properties of the released decoy receptor. J Exp Med 179:739, 1994

    Google Scholar 

  48. Yu Y, Chadee K: Entamoeba histolytica stimulates interleukin 8 from human colonic epithelial cells without parasite-enterocyte contact. Gastroenterology 112:1536–1547, 1997

    Google Scholar 

  49. Malinowsky D, Lundkvist J, Layé S, Bartfai T: Interleukin-1 receptor accessory protein interacts with the type II interleukin-1 receptor. FEBS Lett 429:299–302, 1998

    Google Scholar 

  50. Rauschmayr T, Groves RW, Kupper TS: Keratinocyte expression of the type 2 interleukin 1 receptor mediates local and specific inhibition of interleukin 1-mediated inflammation. Proc Natl Acad Sci USA 94:5814–5819, 1997

    Google Scholar 

Download references

Authors
  1. Andrew W. Stadnyk
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Moorix M.W. Yeung
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sen Rong Yan
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stadnyk, A.W., Yeung, M.M. & Yan, S.R. Human Colon Carcinomas Constitutively Express and Shed Type II IL-1 Receptor, an IL-1 Antagonist. Dig Dis Sci 48, 1737–1744 (2003). https://doi.org/10.1023/A:1025490911140

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1025490911140

Search

Navigation